Depression in male patients on methadone maintenance therapy
Article first published online: 17 APR 2013
Copyright © 2013 Wiley Publishing Asia Pty Ltd
Special Issue: Perspectives in Malaysian Psychiatry. The publication of this APJP-S was supported by the Dana-Impak-Perdana (D-I-P) UKM, Grants No.: 20012-09. Special thanks to the Head of Project D-I-P-2012-09, Professor Hatta Sidi, & Members: Associate Professor Marhani Midin, Associate Professor Nik Ruzyanei Nik Jaafar. Also special thanks to APJP-S (Malaysia) Chief Coordinator: Professor Maniam Thambu & Research Assistant, Shalna Gopalan
Volume 5, Issue Supplement S1, pages 67–73, April 2013
How to Cite
Baharudin, A., Mislan, N., Ibrahim, N., Sidi, H. and Nik Jaafar, N. R. (2013), Depression in male patients on methadone maintenance therapy. Asia-Pacific Psychiatry, 5: 67–73. doi: 10.1111/appy.12069
- Issue published online: 17 APR 2013
- Article first published online: 17 APR 2013
- methadone maintenance therapy;
Depression is one of the most common psychiatric conditions in men. The aim of the study was to determine the depressive symptoms and associated factors among men on methadone maintenance therapy (MMT).
A cross-sectional study was conducted involving 108 subjects who attended the Drug Clinic at Hospital Kuala Lumpur. The instruments used include the Structured Clinical Interview for Diagnostic and Statistical Manual, Fourth Edition Axis-I Disorder, Beck Depression Inventory and the 15-item International Index of Erectile Function.
The rate of depression was 44.4%. There were significant associations between Malay ethnicity, secondary education level and concurrent illicit cannabis use with depression (P < 0.05). However, there was no significant associations between depression and erectile dysfunction (P = 0.379).
Even though depression is common among men on MMT, it is often missed by the treating doctors. It is important to make the treating doctors aware that depression is a serious clinical condition that has a profound impact on the individual and compliance to treatment.